Bringing the fundamentals into focus…
Back to Madrigal Pharmaceuticals, Inc.
How Madrigal Pharmaceuticals, Inc. stacks up
MDGL · against 170 other Healthcare companies of similar size
Profitability
21/ 100
Near the bottom of its peers.
Ranked #149 of 171 · scores higher than 11% of peers
Bars: peers in each 10-point band of the profitability score18 peers with a profitability score of 20–29, including MDGL · Click a bar to see the companies
Why profitability scores 21?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 87% of peers. Return on invested capital: -44.6% vs peer median 4.7%
- a lower return on assets: weaker than 84% of peers. Return on assets: -26.1% vs peer median 1.7%
- a thinner operating margin: weaker than 80% of peers. Operating margin: -25.1% vs peer median 7.1%
Metric by metric
Position: dot = MDGL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MDGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 166 reported | -44.6% | 9.9% | 5% | 33% | |
| Operating marginHigher is better · 163 reported | -25.1% | 12.8% | 11% | 33% | |
| Return on assetsHigher is better · 164 reported | -26.1% | 4.4% | 9% | 33% | |
| Return on equityHigher is better · 159 reported | -53.3% | 8.9% | 11% | Context only | |
| Gross marginHigher is better · 180 reported | 91.5% | 54.2% | 93% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around MDGL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 4 | 170.4B THB (≈$4.8B) | 98 | 70 | |
| 147 | 34.9B CNY (≈$4.9B) | 22 | 16 | |
| 147 | 13.7B USD | 22 | 45 | |
| 149 | 8.4B USD | 21 | 28 | |
| 149 | 7.3B USD | 21 | 32 | |
| 149 | 9.2B USD | 21 | 39 | |
| 149 | 9.3B USD | 21 | 29 | |
| 153 | 4.7B USD | 20 | 46 | |
| 153 | 6.7B USD | 20 | 19 | |
| 153 | 7.8B USD | 20 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score